Home AVANIR Pharmaceuticals

AVANIR Pharmaceuticals

acquired
Post-IPO Round
Developer of Therapeutic Drugs for Central Nervous System Diseases

Basic Information

AVANIR Pharmaceuticals is a biopharmaceutical company dedicated to providing innovative medications for patients with central nervous system (CNS) disorders who have significant unmet medical needs. They deliver innovative CNS solutions to improve the lives of patients and their care communities. As part of our commitment to enhancing patient care, we provide funding to healthcare providers and other stakeholders to advance the field of CNS disorders.
Avanir Pharmaceuticals, Inc.
California,United States of America
101~500 people
January 01, 1988
bizdev@avanir.com